MedPath
NMPA Approval

Ozagrel Sodium for Injection

国药准字H20058331

August 6, 2024

Drug Information

注射用奥扎格雷钠

注射剂

40mg (按奥扎格雷钠计)

化学药品

August 6, 2024

Company Information

Applicant Company

海南省海口市秀英区秀英街道美安生态科技新城美安二环路48号

Manufacturing Company

泰州市杏林路12号15幢、17幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用奥扎格雷钠 - NMPA 批准文号 | MedPath